Kaul Siddharth, Anantharam Vellareddy, Kanthasamy Arthi, Kanthasamy Anumantha G
Parkinson's Disorder Research Laboratory, Department of Biomedical Sciences, 2062, Veterinary Medicine Building, Iowa Sate University, Ames, IA 50011, USA.
Brain Res Mol Brain Res. 2005 Sep 13;139(1):137-52. doi: 10.1016/j.molbrainres.2005.05.022.
Alpha-synuclein is a pre-synaptic protein of unknown function that has been implicated in the pathogenesis of Parkinson's disease (PD). Recently, we demonstrated that 1-methyl-4-phenylpyridinium (MPP+) induces caspase-3-dependent proteolytic activation of PKCdelta, which subsequently contributes to neuronal apoptotic cell death in mesencephalic dopaminergic neuronal cells. In the present study, we examined whether PKCdelta interacts with alpha-synuclein to modulate MPP+-induced dopaminergic degeneration. Over-expression of wild-type human alpha-synuclein in mesencephalic dopaminergic neuronal cells (N27 cells) attenuated MPP+-induced (300 microM) cytotoxicity, release of mitochondrial cytochrome c, and subsequent caspase-3 activation, without affecting reactive oxygen species (ROS) generation. Wild-type alpha-synuclein over-expression also dramatically reduced MPP+-induced caspase-3-mediated proteolytic cleavage of PKCdelta, whereas over-expression of the mutant human alpha-synucleinA53T did not alter the PKCdelta cleavage under similar conditions. Immunoprecipitation-kinase assay revealed reduced PKCdelta kinase activity in wild-type alpha-synuclein over-expressing cells in response to MPP+ treatment. Wild-type alpha-synuclein over-expression also rescued mesencephalic dopaminergic neuronal cells from MPP+-induced apoptotic cell death, while alpha-synucleinA53T exacerbated the MPP+-induced DNA fragmentation. Furthermore, co-immunoprecipitation studies revealed that alpha-synuclein interacts with the pro-apoptotic proteins PKCdelta and BAD, but not with the anti-apoptotic protein Bcl-2 following MPP+ treatment. We also observed that the interaction between PKCdelta and alpha-synuclein does not involve direct phosphorylation. Together, our results demonstrate that wild-type alpha-synuclein interacts with the pro-apoptotic molecules BAD and PKCdelta to protect dopaminergic neuronal cells against neurotoxic insults.
α-突触核蛋白是一种功能未知的突触前蛋白,与帕金森病(PD)的发病机制有关。最近,我们证明1-甲基-4-苯基吡啶鎓(MPP+)诱导PKCδ的半胱天冬酶-3依赖性蛋白水解激活,随后导致中脑多巴胺能神经元细胞的神经元凋亡性细胞死亡。在本研究中,我们研究了PKCδ是否与α-突触核蛋白相互作用以调节MPP+诱导的多巴胺能变性。在中脑多巴胺能神经元细胞(N27细胞)中过表达野生型人α-突触核蛋白可减轻MPP+(300μM)诱导的细胞毒性、线粒体细胞色素c的释放以及随后的半胱天冬酶-3激活,而不影响活性氧(ROS)的产生。野生型α-突触核蛋白的过表达还显著降低了MPP+诱导的半胱天冬酶-3介导的PKCδ蛋白水解切割,而突变型人α-突触核蛋白A53T的过表达在类似条件下并未改变PKCδ的切割。免疫沉淀激酶分析显示,在MPP+处理后,野生型α-突触核蛋白过表达细胞中的PKCδ激酶活性降低。野生型α-突触核蛋白的过表达还使中脑多巴胺能神经元细胞免受MPP+诱导 的凋亡性细胞死亡,而α-突触核蛋白A53T则加剧了MPP+诱导 的DNA片段化。此外,免疫共沉淀研究显示,在MPP+处理后,α-突触核蛋白与促凋亡蛋白PKCδ和BAD相互作用,但不与抗凋亡蛋白Bcl-2相互作用。我们还观察到PKCδ与α-突触核蛋白之间的相互作用不涉及直接磷酸化。总之,我们的结果表明,野生型α-突触核蛋白与促凋亡分子BAD和PKCδ相互作用,以保护多巴胺能神经元细胞免受神经毒性损伤。